Related Experiment Video
Updated: Aug 8, 2026

09:21
Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
From Recanalization to Failed Recovery: No Reflow, No Rescue, and No Regrow After Thrombectomy
Ariana Chacon1, Dareen Hijazi1, Ali Tfaily1
1Department of Neurosurgery, Emory University School of Medicine, 1365 Clifton Rd, Suite B6200, Atlanta, GA, 30322, USA.
Translational Stroke Research
|August 7, 2026
Summary
Endovascular thrombectomy (EVT) for stroke is technically successful but often fails to restore function. Futile recanalization (FR) occurs due to microvascular issues, secondary brain injury, and poor neuroplasticity, hindering recovery.
Area of Science:
- Neurology
- Vascular Medicine
- Regenerative Medicine
Background:
- Endovascular thrombectomy (EVT) achieves high recanalization rates in acute ischemic stroke with large vessel occlusion (LVO).
- However, successful reperfusion does not consistently lead to functional independence, a phenomenon termed futile recanalization (FR).
- FR underscores the limitations of macrovascular reperfusion alone in stroke recovery.
Purpose of the Study:
- To propose a mechanistic framework for futile recanalization (FR) in acute ischemic stroke.
- To examine the determinants of FR, including microvascular failure, secondary neuronal injury, and impaired neuroplasticity.
- To identify strategies for improving functional outcomes after EVT.
Main Methods:
- Review of clinical, imaging, procedural, and molecular factors contributing to FR.
- Analysis of the "3 R's" of stroke recovery: No-Reflow, No-Rescue, and No-Regrow.
- Synthesis of current understanding of the mechanisms underlying futile recanalization.
Main Results:
- Futile recanalization (FR) is driven by microvascular dysfunction (No-Reflow), secondary neuronal loss (No-Rescue), and impaired neuroplasticity (No-Regrow).
- No-Reflow involves capillary obstruction and endothelial injury.
- No-Rescue results from neuroinflammation and blood-brain barrier breakdown.
- No-Regrow is characterized by failed neurogenesis and axonal degeneration.
Conclusions:
- Understanding the multifactorial nature of FR is crucial for improving EVT outcomes.
- Future strategies must address microvascular injury, inflammation, and neuroplasticity.
- Adjunctive therapies targeting downstream perfusion and neuroinflammation are needed to translate angiographic success into functional recovery.
Related Concept Videos
Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Ischemic Stroke ll: Pathophysiology
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Aneurysm III: Interprofessional Care
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
